Chiropractors in West Lawn, PA Accepting Medicare
6 Chiropractors found. Showing 1 - 6
 Dr. Dean A Wolf, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1813 Penn Ave, West Lawn, PA 19609 Phone: 610-374-3861 Fax: 610-372-8019 |
 Witmer Chiropractic Associates Chiropractor Medicare: Medicare Enrolled Practice Location: 2112 Penn Ave, West Lawn, PA 19609 Phone: 610-670-8550 |
Wolf Chiropractic Center Of Wyomissing Chiropractor Medicare: Medicare Enrolled Practice Location: 1813 Penn Ave, West Lawn, PA 19609 Phone: 610-374-3861 Fax: 610-372-8019 |
 Alicia Virga Witmer, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2112 Penn Ave, West Lawn, PA 19609 Phone: 610-670-8550 |
In Sync Tonal Chiropractic Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 2419 Penn Ave, West Lawn, PA 19609 Phone: 610-621-6066 |
Eric Todd Witmer, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2112 Penn Ave, West Lawn, PA 19609 Phone: 610-670-8550 |
News Archive
Patients and families save time and money with telemedicine visits
Patients and families who use telemedicine for sports medicine appointments saved an average of $50 in travel costs and 51 minutes in waiting and visit time, according to a new study by Nemours Children's Health System. Each telemedicine visit also saved the health system an average of $24 per patient, researchers reported at the American Academy of Pediatrics National Conference & Exhibition.
Heart and kidney patients should keep taking their medicines during COVID-19 pandemic
As the COVID-19 pandemic unfolds, inaccurate medical information has flooded social media and other channels.
US-Ireland partnership awarded £2.9m to develop nanomedicine for treatment of pancreatic cancer
A US-Ireland partnership involving researchers at Queen's University Belfast has been awarded £2.9m to develop new treatments for pancreatic cancer, which is the fifth most common cause of cancer deaths in the UK.
Biosante to purchase $25.1 million shares of common stock in registered direct offering
BioSante Pharmaceuticals, Inc. today announced that it has received commitments from several institutional investors to purchase $25.1 million of securities in a registered direct offering.
NMS Labs develops substance identification tests for nine 'bath salts' compounds
In keeping up with drug abuse trends, NMS Labs has developed substance identification tests for the nine "bath salts" compounds listed in the recently approved PA Senate Bill 1006.
› Verified 6 days ago
Chiropractors
Physical Therapists
Podiatrists
Occupational Therapists
Optometrists
Speech-Language Pathologists